Contraception with megestrol acetate implants. Megestrol acetate levels in plasma and the influence on the ovarian function
- 1 June 1976
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 13 (6) , 685-695
- https://doi.org/10.1016/0010-7824(76)90120-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkeyContraception, 1976
- Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in womenContraception, 1975
- Further studies on long-term contraception by subcutaneous silasticR∗ capsules containing megestrol acetateContraception, 1972
- Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroidsContraception, 1972
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1971
- Longterm contraception by subcutaneous silasticR capsules containing megestrol acetateContraception, 1970
- EXCRETION OF [6-14C]MEGESTROL ACETATE (6 METHYL-17 ACETOXYPREGNA-4,6 DIENE, 3,20 DIONE) RELEASED FROM SUBCUTANEOUS SILASTIC IMPLANTS IN WOMENReproduction, 1970
- Use of subcutaneous Silastic capsules for long-term steroid contraceptionAmerican Journal of Obstetrics and Gynecology, 1970
- Fertility control in women with a progestogen released in microquantities from subcutaneous capsulesAmerican Journal of Obstetrics and Gynecology, 1969
- Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsulesAmerican Journal of Obstetrics and Gynecology, 1969